Here at Kerafast, we recently added the first patient-derived xenograft model to our online platform. Developed at Virginia Commonwealth University, this xenograft was derived from a 74-year-old female patient with non-small cell lung cancer (NSCLC) and fully characterized in an Oncotarget journal article. The xenograft’s addition to our catalog prompted us to ask the question: 

Continue Reading…